Bookmark
Forward
Progress in elucidation of molecular pathophysiology and its application in therapeutic decision-making for myeloproliferative neoplasms.
Katsuto Takenaka
International journal of hematology 2020 Feb
Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Katsuto Takenaka.
Progress in elucidation of molecular pathophysiology and its application in therapeutic decision-making for myeloproliferative neoplasms.
International journal of hematology.
2020 Feb;111(2):180-181
Mesh Tags
Decision Making
Humans
Janus Kinase 2
Mutation
Myeloproliferative Disorders
Prognosis
Substances
JAK2 protein, human
Janus Kinase 2
PMID: 31907735
View Full Text